Thursday, December 26, 2013

Case against Diamondback Drugs, LLC for Patent Infringement filed by Pegasus Laboratories was dismissed

U.S. District Court
DISTRICT OF KANSAS (Kansas City)
CIVIL DOCKET FOR CASE #: 2:13-cv-02334-EFM-GLR


Pegasus Laboratories, Inc. v. Diamondback Drugs, LLC
Assigned to: District Judge Eric F. Melgren
Referred to: Magistrate Judge Gerald L. Rushfelt
Cause: 35:145 Patent Infringement

Date Filed: 07/10/2013
Date Terminated: 11/20/2013
Jury Demand: Plaintiff
Nature of Suit: 830 Patent
Jurisdiction: Federal Question
Plaintiff
Pegasus Laboratories, Inc.represented byRobert C. Garrison 
Lathrop & Gage, LLP - KC
2345 Grand Boulevard, Suite 2200
Kansas City, MO 64108-2618
816-292-2000
Fax: 816-292-2001
Email: cgarrison@lathropgage.com
LEAD ATTORNEY
ATTORNEY TO BE NOTICED

V.
Defendant
Diamondback Drugs, LLC

Date Filed#Docket Text
07/10/20131 COMPLAINT (No Summons Issued) with trial location of Kansas City, filed by Pegasus Laboratories, Inc. (ta) (Entered: 07/10/2013)
07/10/20132 CIVIL COVER SHEET re: 1 Complaint by Plaintiff Pegasus Laboratories, Inc. (ta) (Entered: 07/10/2013)
07/10/20133 DESIGNATION OF PLACE OF TRIAL filed by Plaintiff Pegasus Laboratories, Inc. - trial to be held in Kansas City. (ta) (Entered: 07/10/2013)
07/10/2013 FILING FEE PAID: in the amount of $400.00, receipt number K4631039367. (ta) (Entered: 07/10/2013)
07/10/20134 AO FORM 120: REPORT on the Filing or Determination of an Action Regarding a Patent or Trademark. (Attachments: # 1 Complaint and Exhibits) (ta) (Entered: 07/10/2013)
11/05/2013 SUMMONS ISSUED as to Diamondback Drugs, LLC. Summons issued and emailed to Plaintiff's Attorney for service. (This is a TEXT ENTRY ONLY. There is no.pdf document associated with this entry.) (ta) (Entered: 11/05/2013)
11/20/20135 NOTICE OF VOLUNTARY DISMISSAL by Pegasus Laboratories, Inc. Without Prejudice. (Garrison, Robert) (Entered: 11/20/2013)
11/20/2013 ***Civil Case Terminated. See 5 Voluntary Dismissal Without Prejudice pursuant to Fed. R. Civ. P. 41(a)(1). (mg) (Entered: 11/21/2013)

No comments: